ICL (Israel Chemicals) has announced its plans to invest $20 million on developing its manufacturing capacity and on R&D support capabilities for its ROVITARIS® alternative protein technology, as the meat alternative market continues to develop as an unstoppable global movement.
The company, which reports annual sales of approximately $600 million, offers solutions for meat, poultry and seafood as well as for dairy. Its new “ROVITARIS” proprietary technology supports the production of allergen free plant-based food which it says can be adapted to meat, poultry or seafood substitute applications “to significantly improve taste and texture”
According to the press release, ROVITARIS, which was awarded most Innovative Ingredient, has excellent freeze & thaw stability, which results in reduced costs for food manufacturers. It states a key advantage is its flexible use in conjunction with a variety of vegetable protein sources. ROVITARIS is said to provide solutions for burgers, hot dogs, deli meats, nuggets and fish sticks, providing on-trend innovation in the form of alternative protein solutions for vegan, vegetarian, and flexitarian consumers.
Ofer Lifshitz, President of ICL Phosphate Solutions, stated: “Responsive adaptability is our key to serving ICL’s customers. As a market leading technology, ROVITARIS® enables manufacturers to create the products that consumers demand while expanding their product development to include new exciting applications.”
